Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT. - Belanger,C.; Esperou-Bourdeau,H.; Bordigoni,P.; Jouet,J.P.; Souillet,G.; Milpied,N.; Troussard,X.; Kuentz,M.; Herve,P.; Reiffers,J.; Demeocq,F.; Dauriac,C.; et al. (Bone Marrow Transplant, 1993)